Leukocyte Interleukin Injection (LI) Immunotherapy Extends Overall Survival (OS) in Treatment-Naive Low-Risk (LR) Locally Advanced Primary Squamous Cell Carcinoma of the Head and Neck: the IT-MATTERS Study.Eyal Talor, Dusan Markovic,Philip T. Lavin, John Cipriano,Jozsef Timar,Andrey Karpenko,Igor Bondarenko,Srboljub Stosic,Hrvoje Sobat,Jayamini Horadugoda, Aliaksandr Zhukavets,Rajnish Vasant Nagarkar, Nazim Imamovic,Chih-Yen Chien,Magdalena Bankowska-Wozniak, Mihaly Kisely,Raphael Feinmesser, James Edward Young, Christopher L. Oliver,Sheng-Po HaoJOURNAL OF CLINICAL ONCOLOGY（2022）引用 0|浏览39暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
